Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,500 shares at $63.12 ($470K) on 2013-11-15, disclosed to the SEC on 2013-11-19.
Scheduled sale ($470k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.58 | 1,100 | $68K | 14.4% |
| 2 | $62.62 | 4,200 | $263K | 56.0% |
| 3 | $63.12 | 2,200 | $139K | 29.6% |
| Total | $62.61 avg | 7,500 | $470K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |